Aug 31 2024
According to the results of a newly published study, “psilocybin is highly effective in reducing depressive symptoms severity” among patients with major depressive disorder and treatment-resistant depression. Published in the journal Brain Sciences, the study is titled Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis …
Aug 30 2024
Researchers at the University of Southern Santa Catarina in Brazil have conducted a comprehensive review, revealing the potential of “classic psychedelics” such as LSD, psilocybin, and ayahuasca in treating alcohol use disorder (AUD). The study, published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry, highlights the pharmacotherapeutic effects of these substances, particularly in cases …
Aug 29 2024
A significant majority of nursing students believe that patients should have legal access to medical marijuana, yet many report a lack of adequate training on the subject during their education, according to a recent survey published in the journal Nurse Practitioner. Researchers from Simmons College in Boston conducted a survey of over 100 nurse practitioner …
Aug 29 2024
The past-year use of cannabis and psychedelics (referred to in the study as hallucinogens) stayed at historically high levels in 2023 among adults aged 19 to 30 and 35 to 50, according to the latest findings from the Monitoring the Future survey. In contrast, past-year use of cigarettes remained at historically low levels in both adult groups. …
Aug 29 2024
According to a new meta-analysis of clinical trials, “cannabinoids are associated with improved quality of life in both CD and UC, as well as improved disease activity”. Titled Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease, the study was published in the journal Inflammatory Bowel Diseases, issued by Oxford University, and it …
Aug 28 2024
The University of California (UC) is seeking participants for a double-blind, randomized clinical trial “examining the preliminary efficacy of psilocybin therapy for people with chronic low back pain”. “This study evaluates whether psilocybin therapy helps patients cope with chronic low back pain more effectively”, states a public posting .” Patients may be recruited at Stanford and University …
Aug 28 2024
As the interest in the marijuana compound cannabidiol (CBD) continues to rise, 2024 has been a remarkable year for research into its potential benefits and applications. Recently we covered the top marijuana studies published so far in 2024, as well as the top THC studies. In this article, we will cover what we believe to …
Aug 28 2024
A new study published in the peer-reviewed journal Cannabis and Cannabinoid Research and available online through the National Institutes of Health found that when it comes to COVID-19, “Cannabis users had better outcomes and mortality compared with non-users”. The research, which utilized data from the National Inpatient Sample Database, sought to evaluate the impact of …
Aug 28 2024
A recent international study has found that cannabidiol (CBD) may offer significant relief for patients suffering from drug-resistant epilepsy associated with glycosylphosphatidylinositol-anchored protein deficiencies (GPI-ADs). Published this month in the peer-reviewed journal Cannabis and Cannabinoid Research, the study was conducted by a team of researchers from Italy, Denmark, Brazil, Germany, and the United States. The …
Aug 26 2024
An NFL-funded study published in the journal Sports Medicine reveals the growing role of marijuana as a therapeutic tool for athletes, highlighting its potential to address issues like pain, anxiety and brain injuries, while also acknowledging the complications and lack of knowledge caused by strict laws and regulations. “The increasing legalization of Cannabis sativa plant …
